Abstract
Many varied pain treatment options exist for pain syndromes secondary to gastrointestinal malignancies and its associated treatments. Systemic therapy using the WHO analgesic ladder is a reasonable initial choice even for practitioners without special training in pain management. Unfortunately, many of these medications are either insufficient when used as monotherapy or associated with intolerable medication-related adverse side effects. In the sections below, we will focus on some techniques that may be considered for common pain syndromes associated with gastrointestinal malignancies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chiu TY, Hu WY, Chen CY. Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2000;8:311–3.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982;50:1913–8.
Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care. 1995;11:27–32.
Portenoy RK, et al. Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer. 1994;74:907–15.
Vainio A, Auvinen A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manag. 1996;12:3–10.
Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in four cancers. Cancer. 1987;60:2563–9.
Bruera E, Portenoy R (eds.). Cancer pain assessment and management. Cambridge UK: Cambridge University Press; 2009. ISBN: 978-0521879279
Sykes N, Bennet M, Yuan C. Clinical pain management. 2nd Edition. Cancer Pain. Boca Raton, FL: CRC Press; 2008. ISBN: 978-0340940075.
Grahm AL, Andrén-Sandberg A. Prospective evaluation of pain in exocrine pancreatic cancer. Digestion. 1997;58:542–9.
Deraco M, Laterza B, Kusamura S, Baratti D. Updated treatment of peritoneal carcinomas: a reviewMinerva Chir. 2007;62:459–76.
Suzuki M, et al. Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and μ-opioid receptors in the spinal cord of mice. Anesthesiology. 2012;117:847–56.
Russo P. Urologic emergencies in the cancer patient. Semin Oncol. 2000;27:284–98.
Nduka CC, Monson JRT, Menzies-Gow N, Darzi A. Abdominal wall metastases following laparoscopy. Br J Surg. 1994;81:648–52.
Foley KM. Pain syndromes in patients with cancer. Med Clin North Am. 1987;71:169–84.
Borad MJ, et al. Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature. Yale J Biol Med. 2009;82:1–6.
Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gastric Cancer. 2011;11:38–45.
Roth ES, et al. Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression. BMC Cancer. 2009;9:274.
Santini D, et al. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2012;23:2072–7.
Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg. 1988;16:121–76.
Mercadante S, Villari P, Ferrera P, Arcuri E, David F. Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. Clin J Pain. 2009;25:648–9.
Luger NM, et al. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain. 2002;99:397–406.
Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249:9–17.
Boelens OB, Scheltinga MR, Houterman S, Roumen RM. Management of anterior cutaneous nerve entrapment syndrome in a cohort of 139 patients. Ann Surg. 2011;254:1054–8.
Akhnikh S, de Korte N, de Winter P. Anterior cutaneous nerve entrapment syndrome (ACNES): the forgotten diagnosis. Eur J Pediatr. 2014;173:445–9.
Kinsella TJ, et al. Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. Int J Radiat Oncol. 1991;20:697–701.
Yi SK, et al. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys. 2012;84:376–82.
Wj M. Surgical management of radiation enteropathy. Surg Clin North Am. 1991;71:977–90.
Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290–5.
Polati E, et al. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg. 1998;85:199–201.
Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology. 2000;92:347–54.
Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg Spine. 2004;100:254–67.
Kapural L, Rakic M. Spinal cord stimulation for chronic visceral pain secondary to chronic non-alcoholic pancreatitis. J Clin Gastroenterol. 2008;42:750–1.
Kim JK, Hong SH, Kim M-H, Lee J-K. Spinal cord stimulation for intractable visceral pain due to chronic pancreatitis. J Korean Neurosurg Soc. 2009;46:165.
Khan YN, Raza SS, Khan EA. Application of spinal cord stimulation for the treatment of abdominal visceral pain syndromes: case reports. Neuromodulation Technol Neural Interface. 2005;8:14–27.
Saito O, et al. Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain. Can J Anaesth J Can Anesth. 2006;53:891–8.
Jackson K, et al. Burst’ ketamine for refractory cancer pain: an open-label audit of 39 patients. J Pain Symptom Manag. 2001;22:834–42.
Mercadante S, Villari P, Ferrera P. Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manag. 2003;25:302–5.
Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage. 2000;20:246–52.
Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med Malden Mass. 2012;13:263–9.
Kosharskyy B, Almonte W, Shaparin N, Pappagallo M, Smith H. Intravenous infusions in chronic pain management. Pain Physician. 2013;16:231–49.
Day M. Sympathetic blocks: the evidence. Pain Pract Off J World Inst Pain. 2008;8:98–109.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pak, D., Hung, J.C. (2019). Gastrointestinal Cancer Pain. In: Gulati, A., Puttanniah, V., Bruel, B., Rosenberg, W., Hung, J. (eds) Essentials of Interventional Cancer Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-319-99684-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-99684-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99682-0
Online ISBN: 978-3-319-99684-4
eBook Packages: MedicineMedicine (R0)